Expert Insights On Patient Recruitment

  1. Going With The Group: Improve Recruitment With Social Psychology And Behavioral Science, Part 2 5/14/2025

    In part two of this series, Tatty Scott explores what social psychology tells us about the magnetic pull of groups on individuals’ behavior and how outreach group engagement activities can maximize behavior change to improve recruitment. 

  2. Improve Patient Recruitment Using Behavioral Science? It's A No-Brainer, Part One 5/14/2025

    In part one of this series, recruitment expert Tatty Scott explores the ways behavioral science — such as nudging the brain’s autopilot — can help change patient behavior and sentiment toward trial participation.

  3. DEI Was Never the Problem, The Way Pharma Did It Was 5/5/2025

    Consultant Denise Bronner details pharma's strategic rollback of DEI initiatives, roles, and even departments and explains why well-meaning but misguided intentions enabled their demise.

  4. 7 Steps For Clinical Investigators To Implement A Robust AI Governance System 5/1/2025

    In part two, Husch Blackwell LLP experts provide practical guidance for clinical investigators on overseeing the use of AI in clinical trials.

  5. Racial Inequities In Medicine: The Consequences Of Historical Unethical Experimentation In Clinical Trials 4/22/2025

    In part two of this series on racial inequities in clinical research, the authors discuss the impact those trials have had on clinical research in the Black community, especially for women.

  6. Racial Inequities In Medicine: The History Of Unethical Race-Based Experimentation 4/21/2025

    Unethical and even brutal clinical research of the 19th and 20th centuries targeted the Black community. Discover how the medical mistreatment of Black patients and participants shaped how the community sees trials today.

  7. Japan's Adoption Of DCTs Is Slow But Steady 4/16/2025

    While global momentum for DCTs accelerates, Japanese healthcare institutions face unique structural and operational hurdles to implement remote and digital trial activities.

  8. Gilead Prioritizes Women With Its First HIV Cure Trial In Africa 3/28/2025

    Gilead’s Head Of HIV Cure Program Strategy Devi SenGupta discusses the challenges and triumphs of a groundbreaking HIV cure trial in South Africa.

  9. As FDA's "Sex Differences" Guidance Reemerges, UCB Reaffirms Importance Of Including Women In Clinical Research 3/26/2025

    UCB Biopharma's Marie Teil explores reasons to prioritize women's inclusion in research and how FDA guidance is poised to support that endeavor.

  10. Gilead Sees Success With HIV PrEP Trial In South Africa 3/24/2025

    Gilead Sciences' Moupali Das, MD, MPH shares how her team completed the Phase 3 trial for HIV PrEP in South Africa amid challenging conditions.